Status:

COMPLETED

Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

High Triglycerides

Hypercholesterolemia

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

This is an open-label pilot study of omega-3 fatty acids (Lovaza) for hypertriglyceridemia in subjects who have been on an atypical (second-generation) antipsychotic medication. The investigators hypo...

Detailed Description

This is an open-label pilot study of omega-3 fatty acids (Lovaza) for hypertriglyceridemia in subjects who have been on an atypical (second generation) antipsychotic medication. Eligible subjects incl...

Eligibility Criteria

Inclusion

  • Female or male patients, 18-75 years of age.
  • Serum triglycerides \>200 mg/dl or high cholesterol \>250 mg/dl
  • Current use of an atypical (second-generation) antipsychotic medication - including clozapine (Clozaril), olanzapine (Zyprexa), risperidone (Risperdal), aripiprazole (Abilify), ziprasidone (Geodon), quetiapine (Seroquel), paliperidone (Invega) - for at least three months

Exclusion

  • Current use of triglyceride or cholesterol-lowering medication other than a statin
  • Current use of omega-3 fatty acid supplement
  • Intake of fish more than twice per week
  • Currently pregnant, or breastfeeding
  • Known hypersensitivity or allergy to omega-3 fatty acids (or any fish allergies)
  • Current use of anticoagulant medication, except for 1 baby aspirin/day - 81mg (coumadin, heparin, Plavix. etc).
  • Consumption of alcohol greater than two drinks per day or active substance abuse
  • Any medical condition that would make participation in the study unsafe, as determined by investigator

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2013

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT00833976

Start Date

July 1 2009

End Date

March 1 2013

Last Update

July 2 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114